Patients with primary biliary cirrhosis have increased serum total antioxidant capacity measured with the crocin bleaching assay

World Journal of Gastroenterology

Volumn 11, Issue 27, 2005, Pages 4194-4198

  Notas, George ^a   Miliaraki, Niki ^a   Kampa, Marilena ^a   Dimoulios, Fillipos ^a   Matrella, Erminia ^a   Hatzidakis, Adam ^a   Castanas, Elias ^a   Kouroumalis, Elias ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

Antioxidants; Chronic hepatitis C; Primary biliary cirrhosis; Serum total antioxidant capacity; Ursodeoxycholic acid; Viral HCV cirrhosis

Indexed keywords

ALBUMIN; ANTIOXIDANT; BILIRUBIN; CROCIN; OXIDIZING AGENT; URIC ACID; URSODEOXYCHOLIC ACID;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; AUTOMATION; BLEACHING; CHRONIC LIVER DISEASE; CLINICAL OBSERVATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; ENZYME ASSAY; FEMALE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRIMARY BILIARY CIRRHOSIS; PROTEIN PROTEIN INTERACTION; STATISTICAL SIGNIFICANCE;

EID: 23144437735     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i27.4194     Document Type: Article

References (30)

1. Jones BE, Czaja MJ. III. Intracellular signaling in response to toxic liver injury. Am J Physiol 1998; 275(5 Pt 1): G874-G878
2. Kaplowitz N. Mechanisms of liver cell injury. J Hepatol 2000; 32: 39-47
3. Loguercio C, Federico A. Oxidative stress in viral and alcoholic hepatitis. Free Radic Biol Med 2003; 34: 1-10
4. Mori N, Hirayama K. Long-term consumption of a methionine-supplemented diet increases iron and lipid peroxide levels in rat liver. J Nutr 2000; 130: 2349-2355
5. Aboutwerat A, Pemberton PW, Smith A, Burrows PC, McMahon RF, Jain SK, Warnes TW. Oxidant stress is a significant feature of primary biliary cirrhosis. Biochim Biophys Acta 2003; 1637: 142-150
6. Paradis V, Kollinger M, Fabre M, Holstege A, Poynard T, Bedossa P. In situ detection of lipid peroxidation by-products in chronic liver diseases. Hepatology 1997; 26: 135-142
7. Ono M, Sekiya C, Ohhira M, Ohhira M, Namiki M, Endo Y, Suzuki K, Matsuda Y, Taniguchi N. Elevated level of serum Mn-superoxide dismutase in patients with primary biliary cirrhosis: possible involvement of free radicals in the pathogenesis in primary biliary cirrhosis. J Lab Clin Med 1991; 118: 476-483
8. Sigal E, Laughton CW, Mulkins MA. Oxidation, lipoxygenase, and atherogenesis. Ann NY Acad Sci 1994; 714: 211-224
9. Stam H, Hulsmann WC, Jongkind JF, van der Kraaij AM, Koster JF. Endothelial lesions, dietary composition and lipid peroxidation. Eicosanoids 1989; 2: 1-14
10. Lyons TJ. Glycation and oxidation: a role in the pathogenesis of atherosclerosis. Am J Cardiol 1993; 71: 26B-31B
11. Offermann MK, Medford RM. Antioxidants and atherosclerosis: a molecular perspective. Heart Dis Stroke 1994; 3: 52-57
12. Longo M, Crosignani A, Battezzati PM, Squarcia GC, Invernizzi P, Zuin M, Podda M. Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis. Gut 2002; 51: 265-269
13. Kampa M, Nistikaki A, Tsaousis V, Maliaraki N, Notas G, Castanas E. A new automated method for the determination of the Total Antioxidant Capacity (TAC) of human plasma, based on the crocin bleaching assay. BMC Clin Pathol 2002; 2: 3
14. Ludwig J, Dickson ER, McDonald GS. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histol 1978; 379: 103-112
15. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA 1993; 90: 7915-7922
16. Halliwell B, Gutteridge JM, Cross CE. Free radicals, antioxidants, and human disease: where are we now? J Lab Clin Med 1992; 119: 598-620
17. McCall MR, Frei B. Can antioxidant vitamins materially reduce oxidative damage in humans? Free Radic Biol Med 1999; 26: 1034-1053
18. Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 1994; 344: 721-724
19. Halliwell B. Antioxidants in human health and disease. Annu Rev Nutr 1996; 16: 33-50
20. Ghiselli A, Serafini M, Natella F, Scaccini C. Total antioxidant capacity as a tool to assess redox status: critical view and experimental data. Free Radic Biol Med 2000; 29: 1106-1114
21. Prior RL, Cao G. In vivo total antioxidant capacity: comparison of different analytical methods. Free Radic Biol Med 1999; 27: 1173-1181
22. Cao G, Booth SL, Sadowski JA, Prior RL. Increases in human plasma antioxidant capacity after consumption of controlled diets high in fruit and vegetables. Am J Clin Nutr 1998; 68: 1081-1087
23. Jackson P, Loughrey CM, Lightbody JH, McNamee PT, Young IS. Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure. Clin Chem 1995; 41: 1135-1138
24. Floreani A, Baragiotta A, Martines D, Naccarato R, D'odorico A. Plasma antioxidant levels in chronic cholestatic liver diseases. Aliment Pharmacol Ther 2000; 14: 353-358
25. Barbaste M, Berke B, Dumas M, Soulet S, Delaunay JC, Castagnino C, Arnaudinaud V, Cheze C, Vercauteren J. Dietary antioxidants, peroxidation and cardiovascular risks. J Nutr Health Aging 2002; 6: 209-223
26. Gluud C, Christensen E. Ursodeoxycholic acid for primary biliary cirrhosis. Cochrane Database Syst Rev 2002; 1: CD000551
27. Szalay F. Treatment of primary biliary cirrhosis. J Physiol Paris 2001; 95: 407-412
28. Rodrigues CM, Fan G, Wong PY, Kren BT, Steer CJ. Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production. Mol Med 1998; 4: 165-178
29. Rodrigues CM, Fan G, Ma X, Kren BT, Steer CJ. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J Clin Invest 1998; 101: 2790-2799
30. Rodrigues CM, Ma X, Linehan-Stieers C, Fan G, Kren BT, Steer CJ. Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation. Cell Death Differ 1999; 6: 842-854